SET: a potent inhibitor of protein phosphatase 2A involved in apoptosis, transcription, nucleosome assembly and histone binding. The translocation t(6;9)(q21;q34.1) NUP214/CAN is found in some cases of acute undifferentiated leukemia (AUL). Two alternatively spliced isoforms have been described. Isoform 1 and isoform 2 interact directly with each other and with ANP32A within the tripartite INHAT (inhibitor of acetyltransferases) complex. Both isoforms inhibit the acetylation of histones (HAT) and nucleosomes, most probably by masking the accessibility of lysines of histones to the acetylases. The predominant target for inhibition is histone H4. HAT inhibition leads to silencing of HAT-dependent transcription and prevents active demethylation of DNA. Both isoforms stimulate DNA replication of the adenovirus genome complexed with viral core proteins; however, isoform 2 specific activity is higher. Isoform 2 anti-apoptotic activity is mediated by inhibition of the GZMA-activated DNase, NME1. In the course of cytotoxic T lymphocyte (CTL)-induced apoptosis, GZMA cleaves SET, disrupting its binding to NME1 and releasing NME1 inhibition.
Protein type: DNA-binding; Inhibitor; DNA replication; Oncoprotein; Nuclear receptor co-regulator; Apoptosis
Chromosomal Location of Human Ortholog: 9q34
Cellular Component: cytoplasm; endoplasmic reticulum; nucleoplasm; nucleus; perinuclear region of cytoplasm; protein complex
Molecular Function: histone binding; protein binding; protein phosphatase inhibitor activity; protein phosphatase type 2A regulator activity
Biological Process: DNA replication; negative regulation of histone acetylation; negative regulation of neuron apoptosis; negative regulation of transcription, DNA-dependent; nucleosome disassembly; regulation of mRNA stability
Show more